Nasus Pharma (NSRX)

• Market cap: $41.8M
• 1 day: 3.78%
• 5 days: -1.92%
• 1 month: -12.29%
• 3 months: 14.42%
• 6 months: 42.8%
• Year to date: -52.72%
• 1 year: -55.38%
• 5 years: -56.73%
• 10 years: -56.73%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Employees: 7